Patients with AML-MRC Benefit from Decitabine in Combination with Low-Dose G-CSF, Cytarabine and Aclarubicin: A Single Center Cohort Study
Leukemia research reports（2022）
Key words
Decitabine,CAG regimen,D-CAG regimen,AML-MRC
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined